European Journal of Cancer

This issue's topics
pp. ix-x(2)

Editorial Board
pp. ii-ii(1)

'Onco-tourism'-season ticket, anyone?
pp. 7-7(1)
Author: Smyth J.F.

EUROCARE
pp. 8-9(2)
Author: Mann J.R.

The role of protein kinase C-alpha (PKC-) in malignancies of the gastrointestinal tract
pp. 10-20(11)
Authors: Lahn M.; Paterson B.M.; Sundell K.; Ma D.

RNA polymerase III transcription-a battleground for tumour suppressors and oncogenes
pp. 21-27(7)
Author: White R.J.

Invariant p53 immunostaining in primary and recurrent breast cancer
pp. 28-32(5)
Authors: Poelman S.M.; Heimann R.; Fleming G.F.; Recant W.M.; Conzen S.D.

Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment
pp. 33-42(10)
Authors: Linderholm B.; Andersson J.; Lindh B.; Beckman L.; Erlanson M.; Edin K.; Tavelin B.; Grankvist K.; Henriksson R.

Cognitive dysfunction and subjective complaints of cancer patients - a cross-sectional study in a cancer rehabilitation centre
pp. 43-49(7)
Authors: Poppelreuter M.; Weis J.; Kulz A.K.; Tucha O.; Lange K.W.; Bartsch H.H.

HER2 and COX2 expression in human prostate cancer
pp. 50-55(6)
Authors: Edwards J.; Mukherjee R.; Munro A.F.; Wells A.C.; Almushatat A.; Bartlett J.M.S.

HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?
pp. 56-63(8)
Authors: Latif Z.; Watters A.D.; Dunn I.; Grigor K.; Underwood M.A.; Bartlett J.M.S.

Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival - a validation study
pp. 64-72(9)
Authors: Holten-Andersen M.; Christensen I.J.; Nilbert M.; Bendahl P.O.; Nielsen H.J.; Brunner N.; Fernebro E.

Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992
pp. 73-83(11)
Authors: Bacci G.; Forni C.; Longhi A.; Ferrari S.; Donati D.; De Paolis M.; Barbieri E.; Pignotti E.; Rosito P.; Versari M.

Serum enterolactone levels and the risk of breast cancer in women with palpable cysts
pp. 84-89(6)
Authors: Boccardo F.; Lunardi G.; Guglielmini P.; Parodi M.; Murialdo R.; Schettini G.; Rubagotti A.

Familial clustering of ovarian and endometrial cancers
pp. 90-95(6)
Authors: Hemminki K.; Granstrom C.

Going up or coming down? The changing phases of the lung cancer epidemic from 1967 to 1999 in the 15 European Union countries
pp. 96-125(30)
Authors: Bray F.; Tyczynski J.E.; Parkin D.M.

Inequalities in lung cancer mortality by the educational level in 10 European populations
pp. 126-135(10)
Authors: Mackenbach J.P.; Huisman M.; Andersen O.; Bopp M.; Borgan J.-K.; Borrell C.; Costa G.; Deboosere P.; Donkin A.; Gadeyne S.; Minder C.; Regidor E.; Spadea T.; Valkonen T.; Kunst A.E.

Genetic analysis of the LKB1/STK11 gene in hepatocellular carcinomas
pp. 136-141(6)
Authors: Kim C.J.; Cho Y.G.; Park J.Y.; Kim T.Y.; Lee J.H.; Kim H.S.; Lee J.W.; Song Y.H.; Nam S.W.; Lee S.H.; Yoo N.J.; Lee J.Y.; Park W.S.

Uptake of 5-fluorouracil (5-FU) in peritoneal metastases in relation to the route of drug administration and tumour debulking surgery - an autoradiographic study in the rat
pp. 142-147(6)
Authors: Mahteme H.; Larsson B.; Sundin A.; Khamis H.; Graf W.

Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells
pp. 148-157(10)
Authors: David A.; Kopeckova P.; Minko T.; Rubinstein A.; Kopecek J.

Model for paraaortic lymph node metastasis produced by orthotopic implantation of ovarian carcinoma cells in athymic nude mice
pp. 158-163(6)
Authors: Tamada Y.; Aoki D.; Nozawa S.; Irimura T.